carbenoxolone sodium has been researched along with Cochlear Hearing Loss in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, L; Wang, J | 1 |
| Albuloushi, A; Lovgren, ML; Martin, PE; Steel, A; Waters, A; Yeoh, Y; Zamiri, M | 1 |
2 other study(ies) available for carbenoxolone sodium and Cochlear Hearing Loss
| Article | Year |
|---|---|
MiR-106a facilitates the sensorineural hearing loss induced by oxidative stress by targeting connexin-43.
Topics: Animals; Antagomirs; Carbenoxolone; Cell Proliferation; Gentamicins; Hearing Loss, Sensorineural; Humans; MicroRNAs; Oxidative Stress; Rats | 2022 |
A heterozygous mutation in GJB2 (Cx26F142L) associated with deafness and recurrent skin rashes results in connexin assembly deficiencies.
Topics: Biological Transport; Carbenoxolone; Cell Survival; Child; Connexin 26; Connexin 43; Endoplasmic Reticulum Stress; Exanthema; Female; Gene Expression; HaCaT Cells; Hearing Loss, Sensorineural; HeLa Cells; Heterozygote; Humans; Microtubules; Mutation; Paclitaxel; Transfection; Tubulin Modulators | 2020 |